Revisiting IDO and its value as a predictive marker for anti-PD-1 resistance
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Translational Medicine"
DOI: 10.1186/s12967-019-1784-8
Abstract: Botticelli et al. proposed the activity of indoleamine-2,3-dioxygenase 1 (IDO) as a potential mechanism and predictive marker for primary resistance against anti-PD-1 treatment in the context of non-small cell lung cancer. However, there are a… read more here.
Keywords: ido value; resistance; revisiting ido; marker ... See more keywords